MedPath

NJEye LLC

NJEye LLC logo
🇺🇸United States
Ownership
Private
Established
2008-01-01
Employees
51
Market Cap
-
Website
http://www.prismvisiongroup.com

Pre-Surgical Ocular Surface Treatment With Intracanalicular Dexamethasone Insert And Effect On Intraocular Lens Measurement Accuracy

Phase 4
Conditions
Ocular Surface Disease
Cataract Surgery
Dry Eye Disease
Interventions
First Posted Date
2020-08-28
Last Posted Date
2020-12-11
Lead Sponsor
Prism Vision Group
Target Recruit Count
35
Registration Number
NCT04530864

DEXTENZA Compared to Topical Steroid Therapy Prior to Cataract Surgery in Patients Who Receive Premium Intraocular Lenses

Phase 4
Completed
Conditions
Cataract
Interventions
First Posted Date
2020-07-21
Last Posted Date
2023-06-22
Lead Sponsor
Prism Vision Group
Target Recruit Count
13
Registration Number
NCT04479748
Locations
🇺🇸

Eye Associates of Vineland, Vineland, New Jersey, United States

Resistance to Antibiotics in Patients Receiving Eye Injections

Completed
Conditions
Retinal Vein Occlusion
Age-Related Macular Degeneration
Diabetic Retinopathy
Interventions
Other: Conjunctival and nasopharyngeal swabs
First Posted Date
2014-04-30
Last Posted Date
2016-06-01
Lead Sponsor
Prism Vision Group
Target Recruit Count
40
Registration Number
NCT02126423
Locations
🇺🇸

NJ Retina, Edison, New Jersey, United States

Observational Study to Evaluate and Compare the Rate and Extent of Inflammation After a Single Intravitreal Injection of Ranibizumab vs. a Single Intravitreal Injection of Aflibercept in Treatment Naive and Treatment Experienced Patients.

Completed
Conditions
Neovascular Age Related Macular Degeneration
First Posted Date
2013-09-13
Last Posted Date
2016-06-01
Lead Sponsor
Prism Vision Group
Target Recruit Count
136
Registration Number
NCT01942213
Locations
🇺🇸

NJ Retina, Edison, New Jersey, United States

© Copyright 2025. All Rights Reserved by MedPath